{ "items": [ "\n\n
\n \n\n \n \n \n \n Coronavirus\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n11 June 2020
\n \n \n \nAn international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Ophthalmology\n \n \n\n \n\n\n
\n \n\n \n16 May 2020
\n \n \n \nOn the UNESCO International Day of Light, The Daylight Award announce the 2020 Laureates, including Russell Foster who receives the award for his clinical studies in humans addressing important questions regarding light.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n27 April 2020
\n \n \n \nRoyal Society Publishing has recently brought out a special issue of 'Interface Focus' on sleep and stress, past and present
\n \n\n \n \n\n \n\n \n \n \n \n Coronavirus\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n6 April 2020
\n \n \n \nNHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Public engagement\n \n \n\n \n\n\n
\n \n\n \n9 March 2020
\n \n \n \nA group of students got a taste of research at Oxford earlier this month when they spent a day analysing data at our Sleep and Circadian Neuroscience Institute.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n27 February 2020
\n \n \n \nThe results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 February 2020
\n \n \n \n\u00a3277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Ophthalmology\n \n \n\n \n\n\n
\n \n\n \n10 October 2019
\n \n \n \nDr Kanmin Xue has won the Ruskell Medal from the Worshipful Company of Spectacle Makers
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Ophthalmology\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n16 May 2019
\n \n \n \nThe Oxford BRC is delighted to announce the appointment of seven new Senior Research Fellows.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Public engagement\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n21 March 2019
\n \n \n \nResearchers in our Sleep and Circadian Neuroscience Institute are working with Havant & South Downs College \r\non a teenage sleep study.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 February 2019
\n \n \n \nResearchers in Oxford have carried out the world\u2019s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD), the UK\u2019s most common cause of sight loss.
\n \n\n \n \n\n \n\n \n \n \n \n Award\n \n \n \n \n Ophthalmology\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n28 January 2019
\n \n \n \nPriya Maharaj has won the Archibald Jackson Prize from Somerville College for achieving a Distinction in the MSc in Sleep Medicine.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n\n \n\n\n
\n \n\n \n19 November 2018
\n \n \n \nBertil Damato will oversee the provision of clinical care to patients with an ocular tumour and develop a research group to focus on ocular melanoma and other eye tumours.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 October 2018
\n \n \n \nThe positive results of the world\u2019s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in this week\u2019s edition of Nature Medicine.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n30 September 2018
\n \n \n \nMillions of people are to be given access to digital treatment for insomnia as an alternative to sleeping pills. Study by Colin Espie et al shows that Sleepio improves wellbeing in nearly three quarters of participants.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 June 2018
\n \n \n \nThe first trial of robot-assisted eye surgery in patients has shown the technique to be both safe and effective.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n SCNi\n \n \n\n \n\n\n
\n \n\n \n12 March 2018
\n \n \n \nResearchers at the Sleep and Circadian Neuroscience Institute (SCNi) have been working with visual artist Martin Kohout to reveal the stories of the night-shift workers who keep London running.
\n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n3 October 2017
\n \n \n \nIn a laboratory study in Oxford, researchers have shown how it might be possible to reverse blindness using gene therapy to reprogram cells at the back of the eye to become light sensitive.
\n \n\n \n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Integrative Neuroimaging\n \n \n \n \n Ophthalmology\n \n \n \n \n Staff development\n \n \n\n \n\n\n
\n \n\n \n8 September 2017
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n\n \n\n\n
\n \n\n \n20 March 2017
\n \n \n \nResearchers have started a new gene therapy clinical trial to treat X-linked retinitis pigmentosa (XLRP), the most common cause of blindness in young people.
\n \n\n \n \n